Key factors in the acquisition of contrast kinetic data for oncology

Journal of Magnetic Resonance Imaging

Volumn 10, Issue 3, 1999, Pages 254-259

  Evelhoch, Jeffrey L ^a,b,c  

^a KARMANOS CANCER INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Data acquisition; Gd DTPA; Heterogeneity; Spatial resolution; Temporal resolution; Tumors

Indexed keywords

GADOLINIUM PENTETATE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

AREA UNDER THE CURVE; ARTICLE; BOLUS INJECTION; CANCER DIAGNOSIS; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; DATA ANALYSIS; DRUG BLOOD LEVEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; SIGNAL PROCESSING;

AREA UNDER CURVE; BLOOD FLOW VELOCITY; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; NEOPLASMS;

EID: 0032853898     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199909)10:3<254::AID-JMRI5>3.0.CO;2-9     Document Type: Article

References (41)

1. Hulka CA, Edmister WB, Smith BL, et al. Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. Radiology 1997;205:837-842.
2. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211:101-110.
3. Daniel BL, Yen Y-F, Glover GH, et al. Breast disease: dynamic spiral MR imaging. Radiology 1998;209:499-509.
4. Orel SG. Differentiating benign from malignant enhancing lesions identified at MR imaging of the breast: are time-signal intensity curves an accurate predictor? Radiology 1999;211:5-7.
5. Nunes LW, Schnall MD, Siegelman ES, et al. Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast. AJR Am J Roentgenol 1997;169:409-415.
6. Weinstein D, Strano S, Cohen P, et al. Breast fibroadenoma: mapping of pathophysiologic features with three-time-point, contrast-enhanced MR imaging - pilot study. Radiology 1999;210:233-240.
7. Esserman L, Hylton N, Yassa L, et al. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 1999;17:110-119.
8. Hawighorst H, Weikel W, Knapstein PG, et al. Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res 1998;4:2305-2312.
9. Mayr NA, Yuh WT, Zheng J, et al. Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging. AJR Am J Roentgenol 1998;170:177-182.
10. Barentsz JO, Berger-Hartog O, Witjes JA, et al. Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging. Radiology 1998;207:791-797.
11. Bonnerot V, Charpentier A, Frouin F, et al. Factor analysis of dynamic magnetic resonance imaging in predicting the response of osteosarcoma to chemotherapy. Invest Radiol 1992;27:847-855.
12. Van Vierzen PB, Massuger LF, Ruys SH, Barentsz JO. Fast dynamic contrast enhanced MR imaging of cervical carcinoma. Clin Radiol 1998;53:183-192.
13. Boehm T, Folkman J, Browder T. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [see comments]. Nature 1997;390:404-407.
14. Furman-Haran E, Grobgeld D, Margalit R, Degani H. Response of MCF7 human breast cancer to tamoxifen: evaluation by the threetime-point, contrast-enhanced magnetic resonance imaging method. Clin Cancer Res 1998;4:2299-2304.
15. Hawighorst H, Knapstein PG, Weikel W, et al. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. Cancer Res 1997;57: 4777-4786.
16. Evelhoch J, Cunnings A, Lucas D, et al. Early detection of therapeutic response by dynamic contrast-enhanced MRI. ISMRM Workshop Syllabus: MR of cancer: Physiology and metabolism. Baltimore: 1996. 61-64.
17. Simpson NE, Evelhoch JL. Deuterium NMR tissue perfusion measurements using the tracer uptake approach: II. Comparison with microspheres in tumors. Magn Reson Med 1999;420:240-247.
18. Simpson NE, He Z, Evelhoch JL. Deuterium NMR tissue perfusion measurements using the tracer uptake approach: I. Optimization of methods. Magn Reson Med 1999;42:42-52.
19. Smith BC, Quimby EH. Use of radioactive sodium as tracer in study of peripheral vascular diseases. Radiology 1945;45:335.
20. Kety SS, Schmidt CF. The nitrous oxide method for quantitative determination of cerebral blood flow in man: theory, procedure and normal values. J Clin Invest 1948;6:476-484.
21. Donahue KM, Weisskoff RM, Burstein D. Water diffusion and exchange as they influence contrast enhancement. J Magn Reson Imaging 1997;7:102-110.
22. Haacke EM, Tkach JA. Fast MR imaging: techniques and clinical applications. AJR 1990;67:258-266.
23. Haase A, Frahm J, Matthaei D, Hannicke W, Merboldt KD. FLASH imaging. Rapid NMR imaging using low flip-angle pulses. J Magn Reson 1986;67:258-266.
24. Kay I, Henkelman RM. Practical implementation and optimization of one-shot T1 imaging. Magn Reson Med 1991;22:414-424.
25. Gowland PA, Leach MO. Fast and accurate measurements of T1 using a multi-readout single inversion-recovery sequence. Magn Reson Med 1992;26:79-88.
26. Tong CY, Prato FS. A novel fast T1-mapping method. J Magn Reson Imaging 1994;4:701-708.
27. Hittmair K, Gomiscek G, Langenberger K, et al. Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med 1994;31:567-571.
28. Pelc NJ. Optimization of flip angle for T1 dependent contrast in MRI. Magn Reson Med 1993;29:695-699.
29. Krishnan S, Chenevert T, Evelhoch JL. Analysis of dynamic contrast-enhanced MRI in tumors: optimization of acquisition parameters. In Proceedings of the ISMRM 7th Scientific Meeting, Philadelphia, 1999.
30. Ernst RR, Anderson WA. Application of Fourier transform spectroscopy to magnetic resonance. Rev Sci Instrum 1966;37:93-102.
31. Kety SS. Peripheral blood flow measurement, In: Potter VR, editor. Methods in medical research. Chicago: Year Book Medical Publishers; 1960. p 223-227.
32. Henderson E, Rutt BK, Lee TY. Temporal sampling requirements for the tracer kinetics modeling of breast disease. Magn Reson Imaging 1998;16:1057-1073.
33. 15O. I. Theory and error analysis. J Nucl Med 1983;24:782-789.
34. Evelhoch JL, McDouall JB, Mattiello J, Simpson NE. Measurement of relative regional tumor blood flow in mice by deuterium NMR imaging. Magn Reson Med 1992;24:42-52.
35. Endrich B, Reinhold HS, Gross JF, Intaglietta M. Tissue perfusion inhomogeneity during early tumor growth in rats. J Natl Cancer Inst 1979;62:387-395.
36. Tozer GM, Lewis S, Michalowski A, Aber V. The relationship between regional variations in blood flow and histology in a transplanted rat fibrosarcoma. Br J Cancer 1990;61:250-257.
37. Evelhoch JL. Tracer measurements of blood flow. In: Gillies RJ, editor. NMR in physiology and biomedicine. San Diego, CA: Academic Press; 1994. p 209-220.
38. Krishnan S, Chenevert TL, Helvie MA, Londy FL. Linear motion correction in three dimensions applied to dynamic gadolinium enhanced breast imaging. Med Phys 1999;26:707-714.
39. Korin HW, Felmlee JP, Ehman RL, Riederer SJ. Adaptive technique for three-dimensional MR imaging of moving structures. Radiology 1990;177:217-221.
40. Taylor NJ, Rowland IJ, Tanner SF, Leach MO. A rapid interleaved method for measuring signal intensity curves in both blood and tissue during contrast agent administration. Magn Reson Med 1993;30:744-749.
41. 1-weighted MRI of a diffusable tracer: Standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-232.